Targeting chemosensitizing doses of toremifene based on protein binding
- 1 January 1993
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 31 (5) , 412-414
- https://doi.org/10.1007/bf00686157
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancerCancer Chemotherapy and Pharmacology, 1990
- Multidrug Resistance: P-glycoprotein and Its Allies--The Elusive FoesJNCI Journal of the National Cancer Institute, 1989
- Binding of Toremifene to Human Serum ProteinsBasic & Clinical Pharmacology & Toxicology, 1988
- PHYSICAL-CHEMICAL PROPERTIES SHARED BY COMPOUNDS THAT MODULATE MULTIDRUG RESISTANCE IN HUMAN-LEUKEMIC CELLS1988
- Quantitation of Toremifene and its Major Metabolites in Human Plasma by High-Performance Liquid Chromatography Following Fluorescent ActivationAnalytical Letters, 1987
- Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.Journal of Biological Chemistry, 1986
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.1984
- Uptake and metabolism of daunorubicin by human leukemia cellsCancer Chemotherapy and Pharmacology, 1982
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982